Mirasol, F. (2025 Special Issue). Outsourcing Next-Gen Therapies Relies on Expertise and Technology: The value of outsourcing partnerships for next-gen biotherapeutics rests in the expertise and technologies that service providers bring to the table. BioPharm International, 38, 4-8.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Mirasol, Feliza. "Outsourcing Next-Gen Therapies Relies on Expertise and Technology: The Value of Outsourcing Partnerships for Next-gen Biotherapeutics Rests in the Expertise and Technologies That Service Providers Bring to the Table."
BioPharm International 38 (2025 Special Issue): 4-8.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Mirasol, Feliza. "Outsourcing Next-Gen Therapies Relies on Expertise and Technology: The Value of Outsourcing Partnerships for Next-gen Biotherapeutics Rests in the Expertise and Technologies That Service Providers Bring to the Table."
BioPharm International, vol. 38, 2025 Special Issue, pp. 4-8.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.